Serum-induced macrophage activation is related to the severity of septic shock

Inflammation Research

Volumn 58, Issue 2, 2009, Pages 89-93

  Peck, G ^a   Andrades, M ^b   Lorenzi, R ^b   Da Costa, M ^b   Petronilho, F ^a   Moreira, J C Fonseca ^b   Dal Pizzol, F ^a,c   Ritter, C ^a,c  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL SÃO JOSÉ   (Brazil)

Author keywords

CARS; Innate immune system; Phagocytes; Sepsis; SIRS

Indexed keywords

CYTOKINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MACROPHAGE ACTIVATION; MORTALITY; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROSPECTIVE STUDY; RAT; SEPSIS; SEPTIC SHOCK; SERUM; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELLS, CULTURED; CYTOKINES; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MIDDLE AGED; NITRIC OXIDE; PHAGOCYTOSIS; PROSPECTIVE STUDIES; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 59049084203     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-8088-z     Document Type: Article

References (30)

1. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001; 16: 83.
2. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002; 166: 1197.
3. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138.
4. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression: from bad to worse. Immunol Res 2001; 24: 273.
5. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163: 316.
6. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, Thizy H, Bienvenu, Gueyffier F, Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006; 32: 1175.
7. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006; 106: 63.
8. Pugin J. Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 2007; 280:21.
9. Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 2005; 78: 325.
10. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2001; 31: 2068.
11. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008; 14: 64.
12. American College of Chest Physicians / Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864.
13. de Souza LF, Ritter C, Pens Gelain D, Andrades M, Bernard EA, Moreira JC, Dal-Pizzol F. Mitochondrial superoxide production is related to the control of cytokine release from peritoneal macrophage after antioxidant treatment in septic rats. J Surg Res 2007; 141: 252.
14. Quinn JP, Carter ME, Markey BK, Carter GR. Miles-Misra technique. Clinical Veterinary Microbiology. Mosby. Philadelphia. USA. 1994; p. 63.
15. Verdon CP, Burton BA, Prior RL. Sample pretreatment whit nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995; 224: 502.
16. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125.
17. Pachot A, Monneret G, Brion A, Venet F, Bohe J, Bienvenu J, Mougin B, Lepape A. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 2005; 33: 31.
18. Docke WD, Randow F, Syrbe U. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 1997; 3: 678.
19. Ertel W, Kremer JP, Kenney J. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995; 85: 1341.
20. Munoz C, Carlet C, Fitting B, Bleriot J, Cavaillon J. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991; 88: 1747.
21. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD. Mechanism of endotoxin desensitization: involvement of IL-10 and transforming growth factor beta. J Exp Med 1995; 181: 1887.
22. Marchant A, Alegre M, Hakim A, Piérard G, Marécaux G, Friedman G, De Groote D, Kahn R, Vincent J, Goldman M. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15: 265.
23. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, Trentz O. Inhibition of the defense system stimulating interleukin-12 interferon-g pathway during critical illness. Blood 1997; 89: 1612.
24. McCall CE, Grosso-Wilmoth LM, LaRue K, Guzman RN, Cousart SL. Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993; 91: 853.
25. Marie C, Muret J, Fitting C, Losser MR, Payen D, Cavaillon JM. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 1998; 91: 3439.
26. Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CG, Tervaert JW. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 2000; 26: 883.
27. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007; 11: R49.
28. Huet O, Obata R, Aubron C, Spraul-Davit A, Charpentier J, Laplace C, Nguyen-Khoa T, Conti M, Vicaut E, Mira JP, Duranteau J. Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 2007; 35: 821.
29. Yeh C-L, Hsu C-S, Chen S-C, Hou Y-C, Chiu W-C, Yeh S-L. Effect of arginine on cellular adhesion molecule expression and leukocyte transmigration in endothelial cells stimulated by biological fluid from surgical patients. Shock 2007; 28: 39.
30. Dal-Pizzol F. Alternative activated macrophage: a new key for systemic inflammatory response syndrome and sepsis treatment? Crit Care Med 2004; 32: 1971.